Induced Pluripotent Stem Cells
"Induced Pluripotent Stem Cells" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Cells from adult organisms that have been reprogrammed into a pluripotential state similar to that of EMBRYONIC STEM CELLS.
Descriptor ID |
D057026
|
MeSH Number(s) |
A11.872.040.500 A11.872.700.500
|
Concept/Terms |
Fibroblast-Derived Induced Pluripotent Stem Cells- Fibroblast-Derived Induced Pluripotent Stem Cells
- Fibroblast Derived Induced Pluripotent Stem Cells
- Fibroblast-Derived IPS Cells
- Cell, Fibroblast-Derived IPS
- Cells, Fibroblast-Derived IPS
- Fibroblast Derived IPS Cells
- Fibroblast-Derived IPS Cell
- IPS Cell, Fibroblast-Derived
- IPS Cells, Fibroblast-Derived
|
Below are MeSH descriptors whose meaning is more general than "Induced Pluripotent Stem Cells".
Below are MeSH descriptors whose meaning is more specific than "Induced Pluripotent Stem Cells".
This graph shows the total number of publications written about "Induced Pluripotent Stem Cells" by people in this website by year, and whether "Induced Pluripotent Stem Cells" was a major or minor topic of these publications.
View timeline visualization
Year | Major Topic | Minor Topic | Total |
---|
2009 | 7 | 1 | 8 |
2010 | 35 | 9 | 44 |
2011 | 67 | 11 | 78 |
2012 | 45 | 9 | 54 |
2013 | 84 | 14 | 98 |
2014 | 79 | 20 | 99 |
2015 | 56 | 25 | 81 |
2016 | 60 | 44 | 104 |
2017 | 77 | 24 | 101 |
2018 | 62 | 36 | 98 |
2019 | 73 | 48 | 121 |
2020 | 66 | 46 | 112 |
2021 | 84 | 30 | 114 |
2022 | 84 | 9 | 93 |
2023 | 68 | 1 | 69 |
2024 | 59 | 23 | 82 |
2025 | 5 | 3 | 8 |
Below are the most recent publications written about "Induced Pluripotent Stem Cells" by people in Profiles.
-
The AMD-associated genetic polymorphism CFH Y402H confers vulnerability to Hydroquinone-induced stress in iPSC-RPE cells. Front Immunol. 2025; 16:1527018.
-
Cellular senescence induced by cholesterol accumulation is mediated by lysosomal ABCA1 in APOE4 and AD. Mol Neurodegener. 2025 Feb 04; 20(1):15.
-
Engineering synthetic signaling receptors to enable erythropoietin-free erythropoiesis. Nat Commun. 2025 Jan 29; 16(1):1140.
-
Assessing in-vitro models for microglial development and fetal programming: a critical review. Front Immunol. 2025; 16:1538920.
-
A de novo missense mutation in PPP2R5D alters dopamine pathways and morphology of iPSC-derived midbrain neurons. Stem Cells. 2025 Jan 17; 43(1).
-
Derivation and Characterization of Isogenic OPA1 Mutant and Control Human Pluripotent Stem Cell Lines. Cells. 2025 Jan 17; 14(2).
-
Derivation of a Human Brain Organoid with Microglia Development. J Vis Exp. 2025 Jan 17; (215).
-
Stem Cells Reprogramming in Diabetes Mellitus and Diabetic Complications: Recent Advances. Curr Diabetes Rev. 2025; 21(4):21-37.
-
DLK-dependent axonal mitochondrial fission drives degeneration after axotomy. Nat Commun. 2024 Dec 30; 15(1):10806.
-
Identification of Disease-Relevant, Sex-Based Proteomic Differences in iPSC-Derived Vascular Smooth Muscle Cells. Int J Mol Sci. 2024 Dec 29; 26(1).